Target Price Playground

GSK
$47.76
Swing & Horizon Engine Need pre-expiry P&L (+3d / +5d), multi-leg ratios, or hedged overlays on GSK? Launch with your exact active legs & +12.0% target.
โšก Quant Efficiency Alert: Bull Call Spread Delivers +211.2% ROI vs +140.7% ROI on Long Call at $53.49 Target
Bull Call Spread cuts entry cost by 30% ($161 vs $228), lowers breakeven to $49.61 (+3.9%), and slashes daily theta burn from $2.28/d to $0.67/d.
Switch to Bull Call Spread โ†’

๐Ÿ“‹ Strategy

Bullish. Unlimited upside, capped loss = premium paid.

๐ŸŽฏ Target

1-Click Institutional Target Anchors:
56d from today

โš™๏ธ Legs

LONG CALL ยท $48 ยท Jan '27
Qty 1 ยท Premium $2.28 ยท ฮ” 0.53
P&L at Expiry Now $48 Target $53 $33 $48 $62
Stock (100 sh) Long Call Now Target
๐Ÿ’ก Stock vs Options at Target

If GSK hits $53 by Jan 15: the long call returns +$321 (140.7%) on $228 risked, vs +$573 (12.0%) for 100 shares on $4,776. Options give 11.7ร— capital efficiency.

๐Ÿ“… Expiry & Gamma Wall Alignment

Options expire Jan 15, 2027 (56 days out). P&L shown is the value at expiry if GSK is at $53.

๐Ÿ“Š Projected Return

P&L if GSK hits $53 by Jan 15
+$321
+140.7% on $228 risked
Max Profit
Unlimited
Unlimited upside
Max Loss
โˆ’$228
Premium paid
Break-even
$50.28
+5.28% from spot
Prob. of Profit at Expiry (PoP)
33.1%
Above breakeven ($50.28) ยท Touch Target: 31%
30-Day Theta Burn (If Flat)
โˆ’$68
29.8% of entry cost ยท Daily ฮ˜: $-2.28/day
Net ฮ” / ฮ˜ / V
52.98 / -2.28 / 7.44
per spread, per $1 move / day / vol pt
๐Ÿ’พ Log in to save ๐Ÿ“Š My Saved Strategies

๐Ÿ“Š P&L Scenarios โ€” what happens at different prices and dates

GSK Price Today +3d (Nov 23) +7d (Nov 27) Dec 8 Dec 27 Jan 15 (exp)
$38 (-20%) -$222 -$223 -$224 -$227 -$228 -$228
$41 (-15%) -$208 -$210 -$213 -$220 -$227 -$228
$43 (-10%) -$173 -$177 -$183 -$198 -$220 -$228
$45 (-5%) -$106 -$112 -$120 -$144 -$189 -$228
$47 (-2%) -$48 -$54 -$63 -$90 -$146 -$228
$48 (0%) โ† spot -$0 -$7 -$16 -$44 -$104 -$228
$49 (+2%) +$54 +$47 +$38 +$9 -$50 -$156
$50 (+5%) +$146 +$139 +$130 +$103 +$48 -$13
$53 (+10%) +$326 +$320 +$312 +$290 +$251 +$226
$53 (+12%) โ† target +$405 +$400 +$393 +$373 +$340 +$321
$55 (+15%) +$530 +$526 +$520 +$503 +$478 +$464
$57 (+20%) +$751 +$748 +$743 +$731 +$715 +$703
Uses GSK's current IV for repricing. P&L includes all legs (stock + options). Qty: 1x.